Hodgkin's Disease

Showing 1 - 25 of 92

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Non-Hodgkin's Lymphoma and Hodgkin's Disease

Recruiting
  • Lymphoma, Non-Hodgkin
  • Hodgkin's Disease
    • Stanford, California
      Stanford University School of Medicine
    Sep 9, 2022

    Hodgkin's Disease, Non-Hodgkin's Lymphoma, Lymphoproliferative Disease Trial in Houston (EBV-specific T cells: A, EBV-specific T

    Recruiting
    • Hodgkin's Disease
    • +3 more
    • EBV-specific T cells: A
    • EBV-specific T cells: B
    • Houston, Texas
    • +1 more
    Jun 28, 2022

    Hodgkin's Disease Trial in Boston (Echo/Stress Echo)

    Active, not recruiting
    • Hodgkin's Disease
    • Echo/Stress Echo
    • Boston, Massachusetts
    • +1 more
    Mar 28, 2022

    Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia Trial in Atlanta, Saint Louis, Columbus

    Active, not recruiting
    • Acute Myelogenous Leukemia
    • +10 more
    • Atlanta, Georgia
    • +2 more
    Feb 9, 2022

    Hodgkin Lymphoma Molecular Profiling and Clinical Outcomes in

    Completed
    • Hodgkin's Disease
      • Louisville, Kentucky
        Norton Cancer Institute
      Dec 14, 2021

      Lymphoma, Hodgkin's Disease, Relapse Trial in Houston (TGFbeta resistant LMP-specific CTLs)

      Active, not recruiting
      • Lymphoma
      • +3 more
      • TGFbeta resistant LMP-specific CTLs
      • Houston, Texas
      • +1 more
      Dec 8, 2021

      Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia, Chronic Myelogenous Leukemia Trial in Winston-Salem

      Recruiting
      • Acute Myelogenous Leukemia
      • +9 more
        • Winston-Salem, North Carolina
          Wake Forest Baptist Health
        Nov 23, 2021

        HIV, Hodgkin's Disease Trial in United States (Vinblastine sulfate, Dacarbazine, Filgrastim)

        Completed
        • HIV Infections
        • Hodgkin's Disease
        • Vinblastine sulfate
        • +4 more
        • Birmingham, Alabama
        • +7 more
        Oct 26, 2021

        CD20+, B-cell Lymphomas, Mantle Cell Lymphoma, Non-Mantle Cell Low Grade B Cell Lymphomas (SLL/CLL) Trial in Baltimore

        Completed
        • CD20+, B-cell Lymphomas
        • +5 more
        • Baltimore, Maryland
          Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
        Oct 4, 2021

        Leukemia, Myeloid, Acute, Leukemia, Lymphoblastic, Acute, Leukemia, Myelocytic, Chronic Trial in Belgium (Mesenchymal stem

        Terminated
        • Leukemia, Myeloid, Acute
        • +8 more
        • Mesenchymal stem cells
        • Isotonic solution
        • Edeghem, Antwerpen, Belgium
        • +9 more
        Aug 31, 2021

        Multiple Myeloma, Non-hodgkin's Lymphoma, Hodgkin's Disease Trial in Stony Brook (TG-0054)

        Completed
        • Multiple Myeloma
        • +2 more
        • Stony Brook, New York
          Stony Brook University Hospital
        Apr 14, 2021

        Leukemia, Myeloid, Chronic, AML, Leukemia, Lymphocytic, Acute Trial in Minneapolis (biological, drug, radiation)

        Terminated
        • Leukemia, Myeloid, Chronic
        • +8 more
        • Stem Cell Transplant
        • +5 more
        • Minneapolis, Minnesota
          Masonic Cancer Center, University of Minnesota
        Dec 31, 2020

        Hodgkin's Disease, Non-Hodgkin's Lymphoma Trial in New York (Vorinostat, Niacinamide, Etoposide)

        Completed
        • Hodgkin's Disease
        • Non-Hodgkin's Lymphoma
        • New York, New York
          Center for Lymphoid Malignancies at CUMC
        Nov 5, 2020

        Related Donors Donating PBSC to a Family Member, Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia Trial in United States

        Completed
        • Related Donors Donating PBSC to a Family Member
        • +7 more
        • Tampa, Florida
        • +11 more
        Sep 3, 2020

        Chronic Myelogenous Leukemia, Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia Trial in Philadelphia (CD3/CD28 Activated

        Terminated
        • Chronic Myelogenous Leukemia
        • +7 more
        • CD3/CD28 Activated T cells
        • Philadelphia, Pennsylvania
          University of Pennsylvania
        Aug 12, 2020

        Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia, Non-Hodgkin's Lymphoma Trial in United States (Infusion of one MPC

        Completed
        • Acute Myelogenous Leukemia
        • +3 more
        • Infusion of one MPC expanded cord unit and one unexpanded cord unit
        • Infusion of two unexpanded cord blood units.
        • Miami, Florida
        • +8 more
        Jun 25, 2020

        Non-Hodgkin's Lymphoma, Hodgkin's Disease Trial in Russian Federation, United States (SB-743921)

        Completed
        • Non-Hodgkin's Lymphoma
        • Hodgkin's Disease
        • Hackensack, New Jersey
        • +7 more
        Jan 9, 2020

        Blood Cancer, Leukemia, GVHD Trial in Stanford (non-myeloablative hematopoietic cell transplantation, Anti-Thymocyte Globulin,

        Completed
        • Blood Cancer
        • +7 more
        • non-myeloablative hematopoietic cell transplantation
        • +8 more
        • Stanford, California
          Stanford University School of Medicine
        Nov 17, 2019

        MDS, AML, Solid Tumors Trial in United States (azacitidine)

        Completed
        • MDS
        • +5 more
        • Berkeley, California
        • +10 more
        Nov 6, 2019

        Hematological Malignancies, Leukemia, Lymphoma Trial in Philadelphia (Matched Sibling Allogeneic Transplantation)

        Completed
        • Hematological Malignancies
        • +4 more
        • Matched Sibling Allogeneic Transplantation
        • Philadelphia, Pennsylvania
          Thomas Jefferson University
        Sep 27, 2019

        Women Treated With Mediastinal Irradiation for Hodgkin's Disease

        Completed
        • Breast Cancer
        • Hodgkin's Disease
        • breast MRI
        • Mammogram
        • Boston, Massachusetts
        • +2 more
        Apr 30, 2019

        Lymphoma, Hodgkin's Disease Trial in Houston (Melphalan, Ara-C, VP-16)

        Completed
        • Lymphoma
        • Hodgkin's Disease
        • Houston, Texas
        • +1 more
        Nov 29, 2018

        Acute Myeloid Leukemia, Acute Leukemia, Chronic Myelogenous Leukemia Trial in Chicago (fludarabine/busulfan, fludarabine/

        Completed
        • Acute Myeloid Leukemia
        • +10 more
        • Chicago, Illinois
          University of Illinois at Chicago Medical Center
        Oct 9, 2018

        Hodgkin's Disease, Lymphoma Trial (Alemtuzumab (Campath-1H))

        Withdrawn
        • Hodgkin's Disease
        • Lymphoma
        • Alemtuzumab (Campath-1H)
        • (no location specified)
        Nov 6, 2018